Instituto Nacional de Perinatología
Mexico City, 11000, Mexico
Location contact
Edgar Barrientos-Galeana, MSc
CONTACT
52 55 5520 9900 ext. 315
Edgar Barrientos-Galeana, MSc
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07558369
The goal of this observational study is to evaluate how blood donors' lifestyle and nutritional status influence the quality of packed red blood cells (pRBCs) during storage and their impact on patient safety in transfused neonates and postpartum women. The main questions it aims to answer are:
1. Are donor lifestyle and nutritional profiles associated with the development of storage lesions in pRBCs? 2. Do these donor-related factors influence clinical outcomes after transfusion in neonates and postpartum women? 3. Are storage lesion in pRBCs associated with clinical outcomes in transfused neonates and postpartum women?
Researchers will compare pRBC units stratified according to donor lifestyle and nutritional profiles to determine differences in storage lesion biomarkers and post-transfusion clinical outcomes.
Trial opening soon.
Get Notified18 year–64 year
All sexes
Observational
Mexico City, 11000, Mexico
Edgar Barrientos-Galeana, MSc
CONTACT
52 55 5520 9900 ext. 315
Edgar Barrientos-Galeana, MSc
PRINCIPAL_INVESTIGATOR
Lifestyle and nutritional status of blood donors impact the quality of packed red blood cells (pRBCs) during storage and influence patient safety. Our study proposes a prospective cohort to profile pRBCs based on blood donors' lifestyle and nutritional assessments. We will use causal and statistical models to associate these profiles with storage lesions and adverse clinical outcomes in transfused neonates and postpartum women.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From donation (baseline) to transfusion or end of storage (up to 42 days)
Quantification of total antioxidant capacity, including hydrophilic and lipophilic antioxidants (vitamins, proteins, lipids, glutathione, and uric acid), reflecting the ability to neutralize free radicals.
Unit of Measure: mmol (Trolox equivalents)
Time frame: From donation (baseline) to transfusion or end of storage (up to 42 days)
Measurement of lipid peroxidation products, including malondialdehyde (MDA), quantified as thiobarbituric acid reactive substances (TBARS) using colorimetric assays.
Unit of Measure: µM MDA
Time frame: From donation (baseline) to transfusion or end of storage (up to 42 days)
Assessment of erythrocyte membrane integrity based on phosphatidylserine externalization, quantified by flow cytometry.
Percentage of phosphatidylserine-positive cells (%)
Time frame: From donation (baseline) to transfusion or end of storage (up to 42 days)
Determination of hemolysis as the percentage of free hemoglobin in the supernatant, quantified using HemoCue Plasma/Low Hb system.
Unit of Measure: % hemolysis
Time frame: Within the first 24 hours post-transfusion and throughout hospitalization
Occurrence of transfusion-related adverse events, including multiorgan dysfunction, infections, hemolytic reactions, transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), length of hospital stay (days), and all-cause mortality.
Instituto Nacional de Perinatologia
Other Gov
Lifestyle of Blood Donors and Its Impact on the Quality of Blood Components During Storage and Patient Safety
Acronym: ESENCIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00023023
Blood Donation, Digestive System Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06138899
Blood Donation
Lilongwe, Malawi
View Trial DetailsNCT06101238
Blood Donation
Minneapolis, Minnesota, United States
View Trial DetailsNCT05678647
Blood Donation
Uppsala, Sweden
View Trial Details